CiteFacts · FDA Drug Shortages · FDA source
Heparin Sodium Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| B. Braun Medical Inc. | Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) | Available | 08/07/2026 |
| B. Braun Medical Inc. | Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) | Available | 08/07/2026 |
| Baxter Healthcare | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) | Available | 08/17/2026 |
| Baxter Healthcare | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | Available | 08/17/2026 |
| Fresenius Kabi USA, LLC | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Available | 08/04/2026 |
| Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59) | Available | 08/07/2026 |
Source facts
Grouped generic ingredient: Heparin Sodium Injection · 8 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Hematology
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.